- Patients treated in outpatient clinics with a documented histological or cytological diagnosis for non-microcytic lung, colorectal, pancreatic or esophago-gastric cancer at an advanced stage, locally advanced or localized not previously treated with systemic chemotherapy and/or radiation therapy who are candidate for chemotherapy in outpatient setting.